Renaissance Technologies - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 11 filers reported holding IMMUCELL CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUCELL CORP
ValueSharesWeighting
Q3 2023$648
+5.9%
121,380
-0.8%
0.00%0.0%
Q2 2023$612
-3.3%
122,389
-0.4%
0.00%0.0%
Q1 2023$633
-17.3%
122,827
-2.1%
0.00%0.0%
Q4 2022$765
-99.9%
125,489
-8.8%
0.00%0.0%
Q3 2022$1,029,000
-23.0%
137,586
-10.5%
0.00%
-50.0%
Q2 2022$1,336,000
-10.5%
153,787
-0.5%
0.00%0.0%
Q1 2022$1,492,000
+11.3%
154,579
-7.8%
0.00%0.0%
Q4 2021$1,341,000
-18.7%
167,616
-4.9%
0.00%0.0%
Q3 2021$1,650,000
-2.5%
176,322
-1.0%
0.00%0.0%
Q2 2021$1,692,000
-6.4%
178,156
-5.0%
0.00%0.0%
Q1 2021$1,808,000
+80.6%
187,578
+11.6%
0.00%
+100.0%
Q4 2020$1,001,000
+18.0%
168,153
+7.7%
0.00%0.0%
Q3 2020$848,000
+30.3%
156,122
+13.4%
0.00%0.0%
Q2 2020$651,000
+45.6%
137,672
+16.8%
0.00%
Q1 2020$447,000
-21.2%
117,872
+7.1%
0.00%
Q4 2019$567,000
+6.0%
110,106
+14.6%
0.00%
Q3 2019$535,000
-10.5%
96,106
+4.5%
0.00%
-100.0%
Q2 2019$598,000
+3.1%
92,006
+0.8%
0.00%0.0%
Q1 2019$580,000
-10.4%
91,306
-0.5%
0.00%0.0%
Q4 2018$647,000
-19.2%
91,806
-4.5%
0.00%0.0%
Q3 2018$801,000
-37.6%
96,100
-48.2%
0.00%0.0%
Q2 2018$1,283,000
+98.9%
185,700
+101.6%
0.00%0.0%
Q1 2018$645,000
-21.8%
92,100
-1.9%
0.00%0.0%
Q4 2017$825,000
+29.3%
93,900
-4.4%
0.00%0.0%
Q3 2017$638,000
+8.9%
98,200
+22.9%
0.00%0.0%
Q2 2017$586,000
+37.6%
79,900
+3.6%
0.00%0.0%
Q1 2017$426,000
-17.0%
77,100
-10.6%
0.00%0.0%
Q4 2016$513,000
-9.5%
86,200
+17.6%
0.00%0.0%
Q3 2016$567,000
+28.0%
73,300
+14.2%
0.00%0.0%
Q2 2016$443,000
+14.2%
64,200
+13.2%
0.00%0.0%
Q1 2016$388,000
+7.8%
56,707
+18.6%
0.00%0.0%
Q4 2015$360,000
+33.8%
47,800
+5.8%
0.00%0.0%
Q3 2015$269,000
+24.0%
45,200
+63.2%
0.00%
Q2 2015$217,000
+59.6%
27,700
+28.2%
0.00%
Q1 2015$136,000
+46.2%
21,600
+12.5%
0.00%
Q4 2014$93,000
+5.7%
19,200
+7.9%
0.00%
Q3 2014$88,000
+29.4%
17,800
+14.8%
0.00%
Q2 2014$68,000
+3.0%
15,500
+13.1%
0.00%
Q1 2014$66,000
+24.5%
13,700
+10.5%
0.00%
Q4 2013$53,000
+1.9%
12,400
+12.7%
0.00%
Q3 2013$52,000
+36.8%
11,000
+10.0%
0.00%
Q2 2013$38,00010,0000.00%
Other shareholders
IMMUCELL CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Bleichroeder LP 101,594$619,7230.14%
PERRITT CAPITAL MANAGEMENT INC 30,000$183,0000.10%
Overbrook Management Corp 35,532$216,7450.06%
WEALTH EFFECTS LLC 15,650$95,4650.05%
Minerva Advisors LLC 11,958$720.05%
SHUFRO ROSE & CO LLC 62,408$380,6890.03%
Strategic Financial Services, Inc, 31,000$189,7200.02%
FLAGSHIP HARBOR ADVISORS, LLC 14,230$86,8030.01%
Essex Financial Services, Inc. 11,000$670.01%
Renaissance Technologies 125,489$7650.00%
View complete list of IMMUCELL CORP shareholders